Your session is about to expire
← Back to Search
EMDR for Suicidal Thoughts
N/A
Waitlist Available
Led By Lisa M Burback, MD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults aged 18 to 65 with suicidal ideation in the last week
adults (ages 18 to 65) with suicidal ideation in the last week.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up comparing one year before to one year after study enrolment.
Awards & highlights
Study Summary
This trial will test whether a specific type of therapy - Eye Movement Desensitization and Reprocessing (EMDR) - is safe and effective for reducing suicidal thoughts in adults.
Who is the study for?
Adults aged 18-65 with recent suicidal thoughts can join this trial if they have a primary care provider, can consent to treatment, and commit to twice-weekly sessions for 12 total. They need their own computer with camera/mic and a private space. They must avoid certain drugs before/after sessions.Check my eligibility
What is being tested?
The trial is testing virtual EMDR therapy's safety and effectiveness against usual care in reducing suicidal ideation. Participants are randomly assigned to either receive EMDR plus usual care or just the usual care, comparing mental health outcomes pre- and post-treatment.See study design
What are the potential side effects?
Potential side effects of EMDR may include temporary increases in distress, vivid dreams, light-headedness during sessions, emergence of new traumatic memories, or changes in emotions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 65 years old and have had thoughts of suicide in the past week.
Select...
I am between 18 and 65 years old and have had thoughts of suicide in the past week.
Select...
I have a computer with a camera and microphone for therapy sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ comparing one year before to one year after study enrolment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~comparing one year before to one year after study enrolment.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Beck Scale for Suicide ideation (BSS)
Columbia Suicide Severity Rating Scale (CSSRS) Recent (self report of past 1 week)
Secondary outcome measures
ACES Questionnaire (ACES)
BDI II (Beck Depression Inventory II)
DERS (Difficulties in Emotion Regulation Scale)
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual EMDRExperimental Treatment2 Interventions
Patients will receive 1 to 3 preparation sessions (which will include psychoeducation and preparation exercises before EMDR), followed by up to 12 EMDR sessions, delivered over encrypted Zoom videoconferencing. EMDR is an evidence based trauma therapy. These EMDR sessions will focus on the experiences, urges or negative thoughts associated with their suicidal thoughts. The sessions will be 90 minutes in length and occur twice per week. This group will also have access to usual psychiatric care, which usually includes a family doctor or psychiatrist, mental health therapist and having access to Edmonton's community mental health programs.
Group II: Treatment as usualActive Control1 Intervention
This group will also have access to usual care, which usually includes a family doctor or psychiatrist, mental health therapist and having access to Edmonton's community mental health programs.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Eye Movement Desensitization and Reprocessing (EMDR)
2010
N/A
~100
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
897 Previous Clinical Trials
387,165 Total Patients Enrolled
Alberta Health servicesOTHER
158 Previous Clinical Trials
649,627 Total Patients Enrolled
Lisa M Burback, MDPrincipal InvestigatorUniversity of Alberta
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I experience severe dissociation, psychosis, or manic symptoms.I have experienced severe symptoms like hearing voices, memory loss, or feeling detached from my emotions.You agree to not use benzodiazepines, cannabis, or illegal drugs 24 hours before or after EMDR sessions.I am between 18 and 65 years old and have had thoughts of suicide in the past week.and wear a gown
Participants must be willing to wear a gown and adhere to the study safety precautions.Participants must be willing to refrain from benzodiazepine, cannabis or illicit substance use in the 24 hours before and after EMDR sessions.I am planning to have or currently undergoing ECT or trauma-focused therapy.The requirements to be eligible for the study are:I am between 18 and 65 years old and have had thoughts of suicide in the past week.People who want to take part need to have a main service provider.I can give consent and attend 12 sessions for my treatment.I have a computer with a camera and microphone for therapy sessions.You are currently pregnant.I have a computer with a camera and microphone for therapy sessions.You have thoughts of suicide but do not have a plan or intention to carry it out.
Research Study Groups:
This trial has the following groups:- Group 1: Virtual EMDR
- Group 2: Treatment as usual
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger